세계의 질량 분석 이미징 시장 보고서(2025년)
Mass Spectrometry Imaging Global Market Report 2025
상품코드 : 1760602
리서치사 : The Business Research Company
발행일 : On Demand Report
페이지 정보 : 영문 175 Pages
 라이선스 & 가격 (부가세 별도)
US $ 4,490 ₩ 6,498,000
PDF (Single User License) help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,490 ₩ 9,393,000
PDF (Site License) help
PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 8,490 ₩ 12,288,000
PDF (Enterprise License) help
PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

한글목차

질량 분석 이미징 시장 규모는 향후 몇 년 동안 강력한 성장세를 보이며 2029년까지 9.2%의 연평균 성장률(CAGR)로 41억 3,000만 달러에 달할 것으로 예상됩니다. 예측 기간 동안의 성장은 공간 오믹스 연구에 대한 관심 증가, 바이오마커 탐색에 대한 활용 증가, 인공지능 도구와의 통합 확대, 임상 진단 애플리케이션 확대, 고해상도 이미징 기술에 대한 수요 증가에 기인할 것으로 보입니다. 예측 기간 동안 주요 동향으로는 고해상도 질량 분석 기술의 발전, 고급 이미징 소프트웨어의 통합, 샘플 조제 방법의 혁신, 하이브리드 이미징 양식의 발전, 데이터 분석 워크플로우의 높은 수준의 자동화 개발 등이 있습니다.

맞춤형 의료에 대한 수요 증가가 향후 질량 분석 이미징 시장의 성장을 견인할 것으로 예상됩니다. 개인맞춤의료는 유전적 체질, 환경, 라이프스타일에 따라 환자 개개인에 맞는 헬스케어 치료를 통해 치료 효과를 향상시키는 것을 목표로 합니다. 개인맞춤의료의 성장을 견인하고 있는 것은 유전체학의 발전으로, 유전자 프로파일을 기반으로 표적화된 치료를 통해 효능을 높이고 부작용을 최소화할 수 있습니다. 질량 분석 이미징은 조직의 상세한 분자 지도를 생성하고, 질병 바이오마커를 식별하고, 개별 환자 프로필에 맞게 설계된 표적 치료법을 쉽게 만들 수 있도록함으로써 맞춤형 의료를 지원합니다. 예를 들어, 2024년 2월 미국 기반의 비영리 단체인 개인화된 의학 연합(Personalized Medicine Coalition)은 FDA가 2023년에 희귀질환에 대한 16개의 새로운 개인화 치료제를 승인했으며, 이는 2022년의 6개에서 증가한 수치라고 보고했습니다. 그 결과, 맞춤형 의료에 대한 수요 증가가 질량 분석 이미징 시장 확대에 기여하고 있습니다.

질량 분석 이미징(MSI) 시장의 주요 기업들은 탈이온화 전기분무 이온화(DESI)와 같은 첨단 기술을 개발하여 다양한 응용 분야에서 보다 정밀하고 상세한 분자 분석을 제공하는 데 주력하고 있습니다. 2023년 6월, 미국의 분석 실험실 기기 제조업체인 Waters Corporation은 샘플 조제나 추출 없이 조직을 포함한 고체 시료를 직접 분석할 수 있는 타겟 이미징 질량 분석기를 출시했습니다. 이 혁신은 감도와 속도를 향상시켜 조직 분석을 강화하고, 더 정확한 저분자 약물 분석을 제공하고, 표적 이미징에서 더 높은 해상도를 제공합니다. 이 장비는 더 빠른 검출을 가능하게 하고 생물학적 연구의 효율성을 향상시킵니다. 정확도와 효능이 향상되어 연구 활동에 큰 이점을 제공합니다. 이러한 발전은 고품질의 상세한 데이터를 제공하여 의약품 개발 및 생물학 연구를 지원합니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향과 전략

제4장 시장 거시경제 시나리오 : 금리·인플레이션·지정학·무역 전쟁·관세·코로나와 회복이 시장에 미치는 영향을 포함한다

제5장 세계의 성장 분석과 전략 분석 프레임워크

제6장 시장 세분화

제7장 지역별·국가별 분석

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 개요

제31장 기타 주요 기업과 혁신적 기업

제32장 세계 시장 : 경쟁 벤치마킹·대시보드

제33장 주요 기업 인수합병(M&A)

제34장 최근의 시장 동향

제35장 시장 잠재력 높은 나라·부문과 전략

제36장 부록

ksm
영문 목차

영문목차

Mass spectrometry imaging (MSI) is a technique that combines mass spectrometry with imaging to visualize the distribution of chemical compounds within biological or material samples. This method allows for the detection of molecules such as lipids, proteins, and metabolites in tissue sections. MSI offers valuable molecular insights that contribute to the understanding of disease mechanisms, tissue structure, and the identification of biomarkers. Its primary goal is to link molecular data with spatial context to provide a deeper insight into biological systems.

Mass spectrometry imaging's key product categories include instruments, consumables, and services. Instruments encompass the devices or equipment used in mass spectrometry imaging to assess the chemical composition of samples by measuring the mass-to-charge ratio of ions. The technology employs various techniques such as matrix-assisted laser desorption or ionization (MALDI), secondary ion mass spectrometry (SIMS), desorption electrospray ionization (DESI), magnetic sector mass spectrometry, and time-of-flight mass spectrometry (TOFMS), among others. These methods have numerous applications, including proteomics, metabolomics, and glycomics, and are utilized by a range of end-users, including pharmaceutical and biotechnology firms, academic institutions, and government organizations.

The mass spectrometry imaging market research report is one of a series of new reports from The Business Research Company that provides mass spectrometry imaging market statistics, including mass spectrometry imaging industry global market size, regional shares, competitors with a mass spectrometry imaging market share, mass spectrometry imaging market segments, market trends and opportunities, and any further data you may need to thrive in the mass spectrometry imaging industry. This mass spectrometry imaging market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The mass spectrometry imaging market size has grown strongly in recent years. It will grow from $2.65 billion in 2024 to $2.90 billion in 2025 at a compound annual growth rate (CAGR) of 9.6%. The growth observed in the historical period can be linked to the growing use of the technology in pharmaceutical research, the rising demand for personalized medicine, increased applications in cancer diagnostics, greater activity in drug discovery and development, and more funding for biomedical research.

The mass spectrometry imaging market size is expected to see strong growth in the next few years. It will grow to $4.13 billion in 2029 at a compound annual growth rate (CAGR) of 9.2%. The growth in the forecast period is expected to stem from an increasing focus on spatial omics research, a higher use in biomarker discovery, growing integration with artificial intelligence tools, expanding clinical diagnostics applications, and a greater demand for high-resolution imaging techniques. Key trends during the forecast period include advancements in high-resolution mass spectrometry technologies, the integration of advanced imaging software, innovations in sample preparation methods, progress in hybrid imaging modalities, and the development of more advanced automation in data analysis workflows.

The increasing demand for personalized medicine is anticipated to drive the growth of the mass spectrometry imaging market in the future. Personalized medicine tailors healthcare treatments to individual patients based on their genetic makeup, environment, and lifestyle, aiming to improve treatment effectiveness. The growth of personalized medicine is fueled by advances in genomics, which allow for targeted treatments based on genetic profiles, enhancing efficacy and minimizing side effects. Mass spectrometry imaging aids personalized medicine by generating detailed molecular maps of tissues, assisting in the identification of disease biomarkers, and facilitating the creation of targeted therapies designed for individual patient profiles. For example, in February 2024, the Personalized Medicine Coalition, a non-profit organization based in the US, reported that the FDA approved 16 new personalized treatments for rare diseases in 2023, up from six in 2022. As a result, the increasing demand for personalized medicine is contributing to the expansion of the mass spectrometry imaging market.

Leading companies in the mass spectrometry imaging (MSI) market are concentrating on developing advanced technologies, such as desorption electrospray ionization (DESI), to offer more precise and detailed molecular analysis for various applications. DESI is an ionization technique that extracts ions from surfaces in ambient conditions using a charged solvent spray, allowing for direct analysis of solid samples, including tissues, without the need for sample preparation or extraction. In June 2023, Waters Corporation, a US-based manufacturer of analytical laboratory instruments, introduced a targeted imaging mass spectrometer. This innovation enhances tissue analysis by improving sensitivity and speed, providing more precise small-molecule drug analysis and offering higher resolution in targeted imaging. The device enables faster detection, improving biological studies' efficiency. It enhances accuracy and effectiveness, significantly benefiting research efforts. This advancement supports drug development and biological research by providing high-quality, detailed data.

In March 2023, Agilent Technologies Inc., a US-based company specializing in advanced analytical, research, and diagnostic solutions, acquired e-MSion for an undisclosed sum. The acquisition aims to enhance Agilent's mass spectrometry tools by incorporating advanced electron capture dissociation (ECD) technology, which will help researchers obtain more precise and detailed information about complex molecules such as proteins. e-MSion is an early-stage company based in the US that focuses on electron capture dissociation (ECD) technology, improving the accuracy of mass spectrometers in analyzing complex molecules.

Major players in the mass spectrometry imaging market are Thermo Fisher Scientific Inc., Danaher Corporation, Hitachi High-Tech Corporation, Shimadzu Corporation, Waters Corporation, Bruker Corporation, Horiba Scientific, JEOL Ltd., SCIEX, Analytik Jena AG, Standard BioTools, TOFWERK AG, Advion Inc., MassTech Inc., CovalX AG, ImaBiotech SAS, MassAnalytica LLC, Ionwerks Inc., Biognosys AG, Spectroswiss Sarl.

North America was the largest region in the mass spectrometry imaging market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the mass spectrometry imaging market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The mass spectrometry imaging market consists of revenues earned by entities by providing services such as quantitative analysis, molecular profiling, chemical imaging, and pathology integration. The market value includes the value of related goods sold by the service provider or included within the service offering. The mass spectrometry imaging market includes sales of specialized detectors, mass spectrometers, testing kits, and sample preparation systems. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Mass Spectrometry Imaging Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on mass spectrometry imaging market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for mass spectrometry imaging ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The mass spectrometry imaging market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

Scope

Table of Contents

1. Executive Summary

2. Mass Spectrometry Imaging Market Characteristics

3. Mass Spectrometry Imaging Market Trends And Strategies

4. Mass Spectrometry Imaging Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Mass Spectrometry Imaging Growth Analysis And Strategic Analysis Framework

6. Mass Spectrometry Imaging Market Segmentation

7. Mass Spectrometry Imaging Market Regional And Country Analysis

8. Asia-Pacific Mass Spectrometry Imaging Market

9. China Mass Spectrometry Imaging Market

10. India Mass Spectrometry Imaging Market

11. Japan Mass Spectrometry Imaging Market

12. Australia Mass Spectrometry Imaging Market

13. Indonesia Mass Spectrometry Imaging Market

14. South Korea Mass Spectrometry Imaging Market

15. Western Europe Mass Spectrometry Imaging Market

16. UK Mass Spectrometry Imaging Market

17. Germany Mass Spectrometry Imaging Market

18. France Mass Spectrometry Imaging Market

19. Italy Mass Spectrometry Imaging Market

20. Spain Mass Spectrometry Imaging Market

21. Eastern Europe Mass Spectrometry Imaging Market

22. Russia Mass Spectrometry Imaging Market

23. North America Mass Spectrometry Imaging Market

24. USA Mass Spectrometry Imaging Market

25. Canada Mass Spectrometry Imaging Market

26. South America Mass Spectrometry Imaging Market

27. Brazil Mass Spectrometry Imaging Market

28. Middle East Mass Spectrometry Imaging Market

29. Africa Mass Spectrometry Imaging Market

30. Mass Spectrometry Imaging Market Competitive Landscape And Company Profiles

31. Mass Spectrometry Imaging Market Other Major And Innovative Companies

32. Global Mass Spectrometry Imaging Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Mass Spectrometry Imaging Market

34. Recent Developments In The Mass Spectrometry Imaging Market

35. Mass Spectrometry Imaging Market High Potential Countries, Segments and Strategies

36. Appendix

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기